Pharma taps Holland and Knight ahead of orphan drug tax fight

Delivered daily, Influence gives you a comprehensive rundown and analysis of all lobby hires and news on K Street.
Jan 10, 2025 View in browser
 
POLITICO Influence Newsletter Header

By Caitlin Oprysko

With help from Daniel Lippman

ORPHAN DRUGMAKERS HIRE HOLLAND & KNIGHT: Manufacturers of drugs for rare diseases have enlisted the help of veteran tax lobbyist Joshua Odintz of Holland & Knight to stave off additional cuts to a tax incentive for the development of such drugs in any reconciliation bill this year.

​Vertex Pharmaceuticals, ​Ipsen Biopharmaceuticals, Takeda Pharmaceuticals, Acadia Pharmaceuticals, ​BioMarin Pharmaceutical and Alkermes have all hired Odintz, a former counsel for the Senate Finance Committee and former Treasury tax policy chief, since November to work on the provision, according to lobbying disclosures.

— President-elect Donald Trump and House Republicans are huddling this weekend to chart their way forward on a massive reconciliation package to, in part, extend a series of expiring tax cuts from the 2017 law. That law spared what’s known as the orphan drug tax credit from being repealed altogether, after aggressive lobbying from drugmakers and advocates for rare disease patients, instead slashing the tax credit for clinical testing costs in half.

— The tax break also survived being targeted by Democrats’ reconciliation package, which also exempted products approved to treat a single rare disease from drug price negotiations. Drugmakers have pushed to expand that exemption as well as for the tax credit’s restoration in upcoming tax talks. However, with Republicans expected to be even more wary of the price tag of any tax extensions, it could be on the chopping block once again to offset the cost of the bill.  

MORE NEW BUSINESS: The Society for Human Resource Management, which represents HR professionals, hired a team at Mercury that includes former Sen. David Vitter (R-La.) and James Messner, a former deputy political director for House Majority Leader Steve Scalise, as employers brace for scrutiny over their diversity, equity and inclusion policies in the new Congress and administration.

— The trade group this summer dropped the “E” from its DEI policy plank amid a backlash from the right that has only accelerated corporate America’s reversal on promoting such policies in the weeks after Trump’s win. The latest high-profile walkback came today, when Meta announced that it would abandon diversity considerations in its hiring, training and supply chain processes. Appointees for the new administration, meanwhile, have pledged to end federal programs in effect.

— And Harmeet Dhillon, Trump’s pick to lead DOJ’s civil rights department, has experience “suing corporations who use woke policies to discriminate against their workers,” Trump noted in announcing the appointment.

— The day of Mercury’s hire, Scalise took aim at inclusionary hiring practices in a radio interview while discussing possible missteps by federal agencies in the lead-up to the New Year’s Day terrorist attack in New Orleans. “Some of these agencies have gotten so wrapped up in the DEI movement that their main focus is diversity and inclusion rather than security. We have to get back to that core mission,” he said.

TGIF and welcome to PI. Send tips: coprysko@politico.com. And be sure to follow me on X: @caitlinoprysko.

KENNEDY’S SHERPA: HHS Secretary-designate Robert F. Kennedy Jr. “has an experienced guide to shepherd him to confirmation in the Senate,” our Marcia Brown, Daniel Payne, Chelsea Cirruzzo, Grace Yarrow and Robert King report: Ken Nahigian, one half of founding duo of strategic comms shop Nahigian Strategies and a former Senate aide who ran Trump’s 2017 transition, according to four people familiar with the matter.

— “After working on Trump’s transition in 2017, he and his firm secured hundreds of thousands of dollars in federal consulting contracts through the Centers for Medicare and Medicaid Services. He once lobbied for health care interests, including the Israeli drugmaker Teva Pharmaceuticals and the Coalition for Access Now, which promotes cannabidiol, a marijuana derivative, for medical purposes.”

— “Nahigian is working with Katie Miller, who was then-Vice President Mike Pence’s communications director and is married to Trump adviser Stephen Miller.” Miller, who is also a Senate alum and works for P2 Pathway Public Affairs, “is handling the communications around Kennedy’s confirmation process” as the onetime Democratic presidential candidate seeks to assuage concerns about his views on everything from vaccines to pesticides and abortion rights.

BLACKBURN AIDE JOINS BGR: Chris Kelly has left the Hill after six years working for Sen. Marsha Blackburn (R-Tenn.), most recently as her health policy director, to join BGR Group. He’ll be a vice president in the firm’s health and life science practice and work with clients in both D.C. and Nashville.

FFYF ADDS 3: First Five Years Fund, an advocacy group pushing for access to quality child care and early learning, is bolstering its government relations operation as advocates gear up for a new Congress and presidential administration.

— The group hired Melissa Edwards as director of operations and chief of staff, Abby Holland as government affairs manager and Holly Evans as a policy and research analyst, and promoted Christy Felling to managing director of communications and marketing.

— Edwards previously served as the executive director of operations for the U.S. Chamber of Commerce Foundation, Holland previously served as senior legislative assistant for former Rep. Abigail Spanberger (D-Va.) and Evans was previously an intern at the Policy Equity Group.

HOW ZELENSKYY HOPES TO WOO THE RIGHT: Ukrainian President Volodymyr Zelenskyy “sat down for a three-hour, expletive-laden interview with American podcaster Lex Fridman this week as part of a Ukrainian push to use nonmainstream media to reach out to Republican lawmakers and their supporters” ahead of Trump’s swearing-in, according to The Washington Post’s David L. Stern.

— As a wave of Ukraine aid skeptics sweeps into power in Washington and Zelenskyy’s troops struggle to beat back Russia’s advances, the Ukrainian leader “has tasked his media team to move beyond traditional Western media — which is always ready to air an interview with the Ukrainian president — and talk to the outlets that other Americans are listening to, especially those who voted for Trump, explained his advisers.”

— Zelenskyy “watched Fridman and Joe Rogan, the most popular podcaster in the United States, and ‘he thought that this is something that hasn’t been tried yet,’ said the individual close to the administration. ‘And to really understand Ukraine and what’s going on in the war, you need more than a two-minute sound bite.’”

ANNALS OF ETHICS: “The Trump Organization on Friday issued a new ethics agreement that it said would govern how the family and President-elect Donald J. Trump would conduct themselves over the next four years to try to avoid conflicts of interest,” The New York Times’ Eric Lipton reports.

— “The measures described in the document largely echo pledges the family made eight years ago, when Mr. Trump first became president,” including the review of major transactions valued over $10 million by an outside ethics attorney as well as keeping the incoming president’s assets in a trust and limiting his access to financial details.

— “But the Trump family is not pledging to halt any new international real estate deals, unlike eight years ago. Instead, it is agreeing only to ‘no new transactions with foreign governments,’ reflecting a plan that was first shared with The New York Times in December.”

— While Eric Trump maintained that the ethics plan goes “above and beyond,” experts “immediately dismissed the moves as insufficient,” pointing, for example, to the company’s announcement earlier this week that it will host a golf tournament in the spring hosted by the Saudi-funded LIV Golf league.

Jobs report

Cartier Esham, CEO of Esham Strategies, will be the new executive director of the Alliance for a Stronger FDA. She succeeds Steven Grossman.

Phylicia Woods is joining Hologic as director of government affairs. She was most recently director of government affairs and alliance development at Grail.

Tyler Hernandez has joined the Brookings Institution as communications director. He was previously a senior director at Narrative Strategies.

Drumfire Public Affairs has promoted Katy Rodriguez to senior vice president and chief of staff. She was previously a vice president.

Durgesh Manjure is joining EPRI as vice president of integrated grid and energy systems. He previously was senior director of resource adequacy planning for Midcontinent Independent System Operator.

— EPRI has also promoted Morgan Scott to vice president of sustainability and global outreach, Steve Chengelis to vice president of nuclear development and fusion, Mike Caravaggio to vice president of fleet reliability and Jeffery Preece to vice president of fleet development and fuels.

Kate Kline will be CEO at MissionWired. She previously has been president of the fundraising firm and is a Zocdoc and Advisory Board alum. She is preceded by MissionWired founder Anne Lewis, who will now be chair of the organization’s board of directors.

Victoria Gemme is now director of policy and regulatory affairs at the National Organization for Rare Disorders. She previously was assistant research director at the Duke-Margolis Institute for Health Policy.

Natalia Berdibekov-Li is now head of U.S. policy at Galaxy Digital. She previously was at the Treasury Department’s Office of Consumer Policy.

Jason Thompson is now president and CFO of The Nuclear Company. He previously was CFO at Redwood Materials.

New Joint Fundraisers

None.

New PACs

American Frontiers (Hybrid PAC)

CA-09 REPUBLICAN NOMINEE FUND 2026 (PAC)

CA-13 REPUBLICAN NOMINEE FUND 2026 (PAC)

Disrupt (PAC)

ME-02 REPUBLICAN NOMINEE FUND 2026 (PAC)

MI-08 REPUBLICAN NOMINEE FUND 2026 (PAC)

National Federation of Stonewall Democrats PAC (Hybrid PAC)

NC-01 REPUBLICAN NOMINEE FUND 2026 (PAC)

NJ-09 REPUBLICAN NOMINEE FUND 2026 (PAC)

NM-02 REPUBLICAN NOMINEE FUND 2026 (PAC)

NV-03 REPUBLICAN NOMINEE FUND 2026 (PAC)

NY-03 REPUBLICAN NOMINEE FUND 2026 (PAC)

OH-09 REPUBLICAN NOMINEE FUND 2026 (PAC)

TX-28 REPUBLICAN NOMINEE FUND 2026 (PAC)

TX-34 REPUBLICAN NOMINEE FUND 2026 (PAC)

WA-03 REPUBLICAN NOMINEE FUND 2026 (PAC)

New Lobbying REGISTRATIONS

Ballard Partners: Advance Financial Administration, LLC

Ballard Partners: Blockchain (US), Inc.

Ballard Partners: Chevron U.S.A. Inc.

Ballard Partners: Vulcan South America Metals & Mining

Capitol Asset Strategies: Ledger

Cgcn Group, LLC: Chey Institute For Advanced Studies

Dentons US LLP: United Cdpap, Inc.

Holland & Knight LLP: Acadia Pharmaceuticals Inc.

Holland & Knight LLP: Alkermes, Inc.

Holland & Knight LLP: Ipsen Biopharmaceuticals, Inc.

Holland & Knight LLP: Takeda Pharmaceuticals America, Inc.

Holland & Knight LLP: Vertex Pharmaceuticals Incorporated

Intersect Public Affairs, LLC: Friends Of The American Latino Museum

J M Burkman & Associates: Steve Warnecke

Mercury Public Affairs, LLC: Cita- The Wireless Association

Miller Strategies, LLC: Red Chamber Group

Sidley Austin LLP: Aptiv Plc

Skyline Capitol LLC: Shipcom Federal Solutions, LLC

The Vogel Group: Sap National Security Services, Inc.

New Lobbying Terminations

Blank Rome LLP: Dnv

Blue Mountain Strategies: Starkey Hearing Technologies

Capitaledge Advocacy Inc. (Formerly Capitaledge Advocacy, LLC): Santa Cruz Metropolitan Transit District

Corbin Strategies LLC: Academy Of Nutrition & Dietetics

Impact Health Policy Partners: Abbott Laboratories

Impact Health Policy Partners: Greater New York Hospital Association

Indiana Chamber Of Commerce, Inc.: Indiana Chamber Of Commerce Inc

Jeffrey J. Kimbell And Associates: Eagle Pharmaceuticals Inc.

Longbow Public Policy Group, LLC: Center For Capital Markets Competitiveness, U.S. Chamber Of Commerce

Mason Street Consulting, LLC: Emd Serono, Inc.

Mccarter & English, LLP: Fgf Brands

Mr. Mark Kopec: 3Pl Operating Inc.

Sage Therapeutics: Sage Therapeutics

Sonosky, Chambers, Sachse, Endreson & Perry, LLP: Democracy 21

Welsh Rose, LLC: Platinum Advisors (On Behalf Of Sutter Health)

Welsh Rose, LLC: Zoll

 

Follow us

Follow us on Facebook Follow us on Twitter Follow us on Instagram Listen on Apple Podcast
 

To change your alert settings, please log in at https://login.politico.com/?redirect=https%3A%2F%2Fwww.politico.com/settings

This email was sent to salenamartine360.news1@blogger.com by: POLITICO, LLC 1000 Wilson Blvd. Arlington, VA, 22209, USA

Unsubscribe | Privacy Policy | Terms of Service

Post a Comment

Previous Post Next Post